RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 24 - per page Next page
Order by
GenOdyssee S.A. announced today that the Journal of antimicrobial Agents and Chemotherapy (AAC*), has accepted a manuscript describing stronger and more sustained inhibitory effect of GenOdyssee's lead antiviral drug candidate, GEA007.1 More
BioCryst and Mundipharma to develop and commercialize Fodosine™ in markets across Europe, Asia and Australasia for use in oncology. More
GP-Pharm S.A. today announced that it received orphan drug designation from the U.S. Food and Drug Administration (FDA) for SarcodoxomeTM, a new Liposomal formulation of doxorubicin hydrochloride, for the treatment of Soft Tissue Sarcoma (STS). More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
The Wellcome Trust Limited and The Institute of Cancer Research announced a new alliance with GlaxoSmithKline to discover, develop and commercialize novel small molecule inhibitors of B-RAF for use as anti-cancer agent, More
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals More
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
Displaying 1..10 of 24 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us